Former Binance chief executive Changpeng Zhao may receive a presidential pardon from the Trump administration, according to FOX Business Senior Correspondent Charles Gasparino’s recent reporting. Sources close to Zhao indicate…
252 search results for “trade”
With an innovative technology addressing a crucial infection-prevention challenge, PolyPid’s technology could shift hospital incentives – and its ~$50M current market cap may position it as a bargain given it’s…
Following an intensive period of engagement at the annual Annapolis Geopolitical Summit, Academy Securities’ analyst reflects on the wealth of insights gathered from military leaders, intelligence professionals, and industry experts.…
Immigration and Customs Enforcement (ICE) has extended its contract with BI Incorporated, a subsidiary of The GEO Group, to continue managing the Intensive Supervision Appearance Program (ISAP) for illegal aliens.…
The Ivanpah Solar Electric Generating System, once celebrated as the world’s largest solar plant, is shutting down after just over a decade of operation. Located in California’s Mojave Desert along…
European financial markets experienced volatility today following reports that NATO allies have issued stern private warnings to Moscow regarding potential responses to airspace violations. According to sources familiar with diplomatic…
Sometimes the most explosive opportunities hide in plain sight. While investors chase household names, this tiny biotech just collected a milestone payment worth nearly 70% of its entire market cap…
InterCure’s Newly Announced Strategic Acquisition of ISHI Comes at Historic Inflection Point as Trump Administration Explores Cannabis Rescheduling The cannabis industry is buzzing with excitement after President Trump’s drug policy…
The Rothschild family is contemplating divesting their significant ownership position in The Economist, a development that could mark the most substantial ownership transformation for the publication since 2015. Lynn Forester…
TL;DR: The global epinephrine market is set to double to $6-7 billion by 2030, and newly-public Nasus Pharma (NYSE: NSRX) is taking aim at the entire industry with an innovative…
Can't find what you're looking for? Try refining your search: